Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Opioid-Refractory Cancer Pain
NCT02137954Phase 3Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- May 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in cancer pain, sponsored by Assistance Publique-Hôpitaux de Marseille. Status: unknown.
02
Drugs
lidocaine
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT02137954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137954.